Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-22-000014
Filing Date
2022-03-16
Accepted
2022-03-16 17:25:51
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 wf-form5_164746593317772.html 5  
1 FORM 5 wf-form5_164746593317772.xml 5 5212
  Complete submission text file 0001457612-22-000014.txt   6702
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Aakalu Girish N (Reporting) CIK: 0001761614 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36289 | Film No.: 22745859